Literature DB >> 21269284

Absence seizures in the first 3 years of life: an electroclinical study of 46 cases.

Roberto Horacio Caraballo1, Francesca Darra, Elena Fontana, Roberto Garcia, Eduardo Monese, Bernardo Dalla Bernardina.   

Abstract

PURPOSE: Early onset absence seizures have been considered a rare heterogeneous group with a poor prognosis. Only few patients may be categorized into well-known syndromes. We have evaluated electroclinical features, evolution, and the nosologic boundaries of early onset absence seizures.
METHODS: Forty-six neurologically normal patients with absence seizures associated with bilateral, synchronic, or asynchronic, and symmetric or asymmetric spike-and-wave paroxysms with onset in the first 3 years of life were included. Patients with abnormal neurologic examination and brain imaging were excluded from the study. KEY
FINDINGS: In our study, 39 patients met the clinical and electroencephalography (EEG) criteria of well-defined epileptic syndromes. Childhood absence epilepsy was found in 11 patients, benign myoclonic epilepsy in infancy in 18 patients, eyelid myoclonic epilepsy in 4, and epilepsy with myoclonic absences in 6. We did not find clinical and EEG criteria of well-recognized epileptic syndromes in seven children. Nine of 11 patients with simple absence seizures became seizure free. All these patients had normal neurologic and neuropsychological evaluations. Of the 35 patients who had absence seizures associated with myoclonic seizures, 20 became seizure free. Fifteen of 35 children continue having seizures. At the last visit, 20 of these 35 patients had normal neurologic and neuropsychological evaluations, 11 presented with mild mental retardation, and 4 with severe mental retardation. SIGNIFICANCE: Epilepsies with absence seizures of early onset are relatively uncommon. Most of the patients had well-defined epileptic syndromes with a variable evolution. The evolution depended on the epileptic syndromes. Wiley Periodicals, Inc.
© 2011 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21269284     DOI: 10.1111/j.1528-1167.2010.02926.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  2 in total

Review 1.  A Review of the New Antiepileptic Drugs for Focal-Onset Seizures in Pediatrics: Role of Extrapolation.

Authors:  Alexis Arzimanoglou; O'Neill D'Cruz; Douglas Nordli; Shlomo Shinnar; Gregory L Holmes
Journal:  Paediatr Drugs       Date:  2018-06       Impact factor: 3.022

2.  Meta-analysis of drug efficacy in adult vs pediatric trials of patients with PGTC seizures.

Authors:  Douglas R Nordli; Emilia Bagiella; Alexis Arzimanoglou; Jinping Wang; Dinesh Kumar; Antonio Laurenza; Jacqueline French
Journal:  Neurology       Date:  2020-04-01       Impact factor: 9.910

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.